Bloomberg Talks Novartis AG CEO Talks Medicinal Sales
Apr 23, 2024
Novartis AG CEO discusses strong performance of established medicines and new drug launches. They explore market acceptance of a new cancer drug, company growth drivers, Swiss cultural identity, global operations, and strategic acquisitions in the pharmaceutical industry.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 2min
Analysis of Pharmaceutical Company Growth and Market Acceptance of New Cancer Drug
01:44 • 3min
Analysis of Company Growth Drivers and Cultural Identity
04:24 • 2min
Exploring Novartis' Swiss Heritage and Global Operations
06:04 • 2min
Strategic Acquisitions and Industry Challenges in Drug Development
08:26 • 3min